| [1] |
de Souza Rugolo LM, Bentlin MR, Mussi-Pinhata M, et al. Late-onset sepsis in very low birth weight infants: a Brazilian Neonatal Research Network Study[J]. J Trop Pediatr, 2014, 60(6): 415-421.
|
| [2] |
Iatta R, Cafarchia C, Cuna T, et al. Bloodstream infections by Malassezia and Candida species in critical care patients[J]. Med Mycol, 2014, 52(3): 264-269.
|
| [3] |
Lollis TR, Bradshaw WT. Fungal prophylaxis in neonates: a review article[J]. Adv Neonatal Care, 2014, 14(1): 17-23.
|
| [4] |
Wynn JL, Tan S, Gantz MG, et al. Outcomes following candiduria in extremely low birth weight infants[J]. Clin Infect Dis, 2012, 54(3): 331-339.
|
| [5] |
Cetin H, Yalaz M, Akisu M, et al. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia[J]. Pediatr Int, 2005, 47(6): 676-680.
|
| [6] |
Kelly MS, Benjamin DK Jr, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants[J]. Clin Perinatol, 2015, 42(1): 105-117, Ⅷ-Ⅸ.
|
| [7] |
Tragiannidis A, Tsoulas C, Groll AH. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines[J]. Mycoses, 2015, 58(1): 10-21.
|
| [8] |
Devlin RK. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit[J]. Adv Neonatal Care, 2006, 6(2): 68-77; quiz 78-79.
|
| [9] |
Adams-Chapman I, Bann CM, Das A, et al. Neuro-developmental outcome of extremely low birth weight infants with Candida infection[J]. J Pediatr, 2013, 163(4): 961-967, e3.
|
| [10] |
李秋平，高昕，黄捷婷，等. PNICU内早产儿真菌性败血症临床特点分析[J]. 临床儿科杂志，2010, 28(6): 531-534.
|
| [11] |
Xia H, Wu H, Xia S, et al. Invasive candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011[J]. Pediatr Infect Dis J, 2014, 33(1): 106-109.
|
| [12] |
Sriram B, Agarwal PK, Tee NW, et al. Systemic candidiasis in extremely low birthweight (ELBW) neonates despite the routine use of topical miconazole prophylaxis: trends, risk factors and outcomes over an 11-year period[J]. Ann Acad Med Singapore, 2014, 43(5): 255-262.
|
| [13] |
Autmizguine J, Guptill JT, Cohen-Wolkowiez M, et al. Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications[J]. Drugs, 2014, 74(8): 891-909.
|
| [14] |
Fernández-Ruiz M, Guinea J, Lora-Pablos D, et al. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance[J]. Clin Microbiol Infect, 2017, S1198-743X(17): 30047-30042.
|
| [15] |
Pansieri C, Pandolfini C, Jacqz-Aigrain E, et al. Fluconazole prophylaxis in neonates[J]. Arch Dis Child, 2015, 100(1): 75-76.
|
| [16] |
Momper JD, Capparelli EV, Wade KC, et al. Population pharmacokinetics of fluconazole in premature infants with birth weights less than 750 grams[J]. Antimicrob Agents Chemother, 2016, 60(9): 5539-5545.
|
| [17] |
Wilkerson J, McPherson C, Donze A. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence[J]. Neonatal Netw, 2010, 29(5): 323-333.
|
| [18] |
Kaufman DA, Morris A, Gurka MJ, et al. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety[J]. Early Hum Dev, 2014, 90(Suppl 1): S87-S90.
|
| [19] |
Castagnola E, Jacqz-Aigrain E, Kaguelidou F, et al. Fluconazole use and safety in the nursery[J]. Early Hum Dev, 2012, 88(Suppl 2): S11-S15.
|
| [20] |
Steimbach LM, Tonin FS, Virtuoso S, et al. Efficacy and safety of amphotericin B lipid-based formulations-a systematic review and Meta-analysis[J]. Mycoses, 2017, 60(3): 146-154.
|
| [21] |
Kamiński DM. Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments[J]. Eur Biophys J, 2014, 43(10-11): 453-467.
|
| [22] |
Newby J. Nosocomial infection in neonates: inevitable or preventable[J]. J Perinat Neonatal Nurs, 2008, 22(3): 221-227.
|
| [23] |
Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis[J]. Am J Perinatol, 2013, 30(2): 131-141.
|
| [24] |
Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors，mortality rates and neurodevelopmental outcomes at 18 to 22 months[J]. Pediatrics, 2006, 117(1): 84-92.
|
| [25] |
Barton M, O′Brien K, Robinson JL, et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls[J]. BMC Infect Dis, 2014, 14(12): 327-337.
|